FedEx’s Big Jump Post Earnings, and Housing Market Headache 6/25/24
CNBC's "Fast Money"
00:00
Analysis of Home Builders and Pharma Sector Performance
Exploring the resilience of home builders amid consumer market challenges and the significance of unemployment rates. Additionally, updates on Novo Nordisk's weight loss drug approval in China, Eli Lilly's collaboration with OpenAI for innovative treatments, and Al-Nilim Pharma's success with heart disease drugs.
Play episode from 18:08
Transcript
